Freenome Reports Updated CRC Blood Test Validation Results
The updated SimpleScreen test showed 80.4% colorectal cancer sensitivity at 90% specificity. Sensitivity was 18.2% for advanced precancerous lesions and 41.9% for high-grade dysplasia.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.